Hormone therapy postmenopause “benefits are more likely to outweigh risks if initiated for symptomatic women before the age of 60 years or within 10 years after menopause”. Read more
“For women who initiate HT more than 10 or 20 years
from menopause onset or when aged 60 years or older,
the benefit-risk ratio appears less favorable than for…”. Read more
“For hot flashes, hormones are given in pills, patches, sprays, gels, or a vaginal ring that deliver hormones throughout the body—known as systemic therapy”. Read more
“Because estrogen stimulates the lining of the uterus, women with a uterus need to take an additional hormone, progestogen, to protect the uterus”. Read more
https://www.menomartha.com/wp-content/uploads/2020/03/MenoMartha-2020-logo-340.png00MWDhttps://www.menomartha.com/wp-content/uploads/2020/03/MenoMartha-2020-logo-340.pngMWD2021-10-11 05:42:532021-10-11 13:37:56Hormone Therapy and Estrogen Plus Progestogen Therapy
“Raloxifene (marketed as Evista), a mixed estrogen activator (agonist) and blocker (antagonist), acts as an activator in bone and as a blocker in the uterus and…”. Read more
“If you would like to find out what information in hormone therapy videos is applicable to you, it may be in your best interest to choose to talk to your health care…”. Read more
“Treatment of bothersome hot flashes and night sweats is the principal reason women use HT. Hormone therapy also treats vaginal dryness and painful sex associated…”. Read more
